BACK
US May Halt J&J Vaccine Due to Concerns About Rare Blood Clots
interestingengineering.com

US May Halt J&J Vaccine Due to Concerns About Rare Blood Clots

The FDA and CDC are already halting the use of the COVID-19 vaccine on federal sites.

Health

Federal health agencies in the United States called for an immediate halt on the distribution of the Johnson & Johnson single-dose COVID-19 vaccine after it emerged that six recipients in the country developed a rare disorder leading to blood clots, a report from The New York Times explains.

The FDA announced, alongside the CDC, that both agencies "are recommending a pause in the use of this vaccine out of an abundance of caution."

The agencies wish to pause the administration of the vaccine to give regulators time to investigate any potential link between the rare blood clots and the vaccine.

Click to continue reading

All six of the recipients who developed the rare disorder were women aged between 18 and 48. One woman died and a second is in a critical condition, the officials explained.